Home > Insider Trading > Filing (0001140361-21-017512)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1731348	Tilray Inc.	TLRY	Medicinal Chemicals & Botanical Products (2833)	824310622

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1860546	A Carl Merton	C/O Tilray, Inc. 745 Fifth Avenue, Suite 1602 New York NY 10151	Chief Financial Officer	No	No	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Class 2 Common Stock	Disposition	2021-05-12	89,000	$14.82	169,105	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Direct

Footnotes

The shares were sold to satisfy tax obligations of the reporting person incurred in connection with the closing of the plan of arrangement (the "Arrangement") between Tilray, Inc. and Aphria Inc. on April 30, 2021, pursuant to which each common share of Aphria Inc. was exchanged for 0.8381 of a share of Class 2 common stock of Tilray, Inc.. The Arrangement was considered a taxable event for Canadian shareholders of Aphria Inc.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from CAD $17.80 to CAD $18.10, inclusive. The reporting person undertakes to provide to Tilray, Inc. any security holder of Tilray, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (1). The weighted average price reported above was converted from the Canadian weighted average price of CAD $17.9857 to USD using an exchange rate of CAD $1.2133=USD $1.00.